Neuralink, owned by Musk, reports a successful brain chip implant

According to Elon Musk, the first implant in a human patient was carried out successfully by his brain-chip business Neuralink.

The US Food and Drug Administration approved Musk's Neuralink to begin its first human study last year.

A microchip was inserted into a human brain as part of the studies to aid patients with neurological conditions like paralysis.

According to the wealthy founder's post on X, "initial results show promising neuron spike detection" for the brain chip.

Spikes are defined by the National Institutes of Health as neuronal activity that transmits information across the body and throughout the brain using chemical and electrical signals.

Are we going to see neuromorphic controlled robots in the near future?

According to Neuralink, a robot surgeon performs the implant, inserting the chip into the part of the brain responsible for motor intention.

Its secondary objective is to allow people to use their thoughts alone to control a computer's keyboard or cursor in addition to aiding with neurological disorders.

In a different post on X, Musk said that the company's initial offering will be named Telepathy.

The trial aims to assess implant and surgical robot safety by testing the wireless brain-computer interface.

Neuralink is not the first company to successfully implant a microchip on a human brain, despite being one of the most well-known neural processor manufacturers.

A paralyzed man was successfully made to walk by the École Polytechnique Fédérale in Lausanne (EPFL), in Switzerland, simply by thinking. This was accomplished by implanting wirelessly communicating electronic implants in his spine and brain to send ideas to his feet and legs, as per a May 2023 article published in the peer-reviewed magazine Nature.

Neuralink has encountered opposition as well. Earlier in January, Reuters revealed that Musk's business had been punished by the US Department of Transportation (DoT) for breaking regulations pertaining to the transportation of hazardous chemicals.

Inspections of the company's facilities in Texas and California last year revealed, according Reuter's reports, that the company had not registered as a transporter of hazardous goods.

According to the reports, inappropriate packaging of hazardous garbage was discovered, including flammable liquid Xylene. The US Centers for Disease Control and Prevention state that Xylene can result in headaches, dizziness, confusion, loss of muscular coordination, and even death.